Dr. Ide brings her diverse experiences in medicine, science, venture capital, and technology in leading Rimidi, a software company focused on improving the lives of individuals living with chronic diseases. Motivated by the belief that we can do much better in managing health as individuals, industry and society, Dr. Ide left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize the healthcare industry. She founded Rimidi Diabetes in 2012, and currently lives in Atlanta, Georgia, with her husband and their four boys. She enjoys sports and travel in her free time.
Despite growth in the market, CMS has been slow to recognize the value that telehealth can bring to clinical encounters by encouraging utilization of telehealth technology through reimbursement models. However, now CMS has taken steps to encourage practices to leverage telehealth and remote monitoring activities through changes to the Quality Payment Program.
Multiple studies have shown improved outcomes by placing pharmacists into diabetes management roles. With a chronic condition such as diabetes, which impacts 29 million Americans, that’s welcome news. As the number of people with diabetes continues to escalate, we are faced with not only a physician shortage, but a provider shortage. We need to embrace the role of healthcare professionals like pharmacists and further expand their impact through the use of digital health technologies, which encourage patient engagement and extend care.
Published: December 17th 2015 | Updated:
Published: April 7th 2018 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.
